NM_000501.4:c.383delT
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000501.4(ELN):c.383delT(p.Val128GlyfsTer9) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. V128V) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000501.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- cutis laxa, autosomal dominant 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, Genomics England PanelApp, G2P
- supravalvular aortic stenosisInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
- autosomal dominant cutis laxaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial thoracic aortic aneurysm and aortic dissectionInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000501.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ELN | NM_000501.4 | MANE Select | c.383delT | p.Val128GlyfsTer9 | frameshift | Exon 8 of 33 | NP_000492.2 | ||
| ELN | NM_001278939.2 | c.383delT | p.Val128GlyfsTer9 | frameshift | Exon 8 of 34 | NP_001265868.1 | |||
| ELN | NM_001278915.2 | c.383delT | p.Val128GlyfsTer9 | frameshift | Exon 8 of 33 | NP_001265844.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ELN | ENST00000252034.12 | TSL:1 MANE Select | c.383delT | p.Val128GlyfsTer9 | frameshift | Exon 8 of 33 | ENSP00000252034.7 | ||
| ELN | ENST00000380562.8 | TSL:1 | c.383delT | p.Val128GlyfsTer9 | frameshift | Exon 8 of 33 | ENSP00000369936.4 | ||
| ELN | ENST00000458204.5 | TSL:1 | c.353delT | p.Val118GlyfsTer9 | frameshift | Exon 7 of 32 | ENSP00000403162.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Supravalvar aortic stenosis Pathogenic:1
While this particular variant has not been reported in the literature, loss-of-function variants in ELN are known to be pathogenic (PMID: 9215670, 11175284). For these reasons, this variant has been classified as Pathogenic. This sequence change deletes 1 nucleotide from exon 8 of the ELN mRNA (c.383delT), causing a frameshift at codon 128. This creates a premature translational stop signal (p.Val128Glyfs*9) and is expected to result in an absent or disrupted protein product.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at